Understanding the Clinical Efficacy of Immune Stimulating Conjugates
Time: 4:45 pm
day: day 1- pm
Details:
- Examining Upifitamab Rilsodotin clinical data
- Showcasing results from the UP-NEXT, Phase III monotherapy trial in platinum sensitive recurrent ovarian cancer
- Exploring results from XMT-1592 and XMT-1660 dose escalation trial results
